Details for New Drug Application (NDA): 050579
✉ Email this page to a colleague
NDA 050579 describes MONOCID, which is a drug marketed by Glaxosmithkline and is included in two NDAs. Additional details are available on the MONOCID profile page.
The generic ingredient in MONOCID is cefonicid sodium. Additional details are available on the cefonicid sodium profile page.
The generic ingredient in MONOCID is cefonicid sodium. Additional details are available on the cefonicid sodium profile page.
Summary for 050579
| Tradename: | MONOCID |
| Applicant: | Glaxosmithkline |
| Ingredient: | cefonicid sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050579
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | May 23, 1984 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | May 23, 1984 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | May 23, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
